The United Laboratories International Holdings Ltd (3933) - Financial and Strategic SWOT Analysis Review
The United Laboratories International Holdings Ltd (3933) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
The United Laboratories International Holdings Ltd (United Lab) is a pharmaceutical company that manufactures and sells pharmaceutical products. The company offers products through divisions such as preparation products, intermediate products, capsule products, raw material products, and health products. It also provides antibiotics, pharmaceutical raw materials and intermediates, material products and healthcare products. Its intermediates include amino-cephalosporanic acid, amino-penicillin acid, and octylammonium clavulanate. United Laboratories' drug products include amoxicillin capsules, ampicillin capsules, clavulana capsules, levofloxacin hydrochlorid, and cefuroxime axetil tablets, among others. It sells its products through a network of distributors in Europe, North America, East Africa and South East Asia. United Lab is headquartered in Hong Kong.
The United Laboratories International Holdings Ltd Key Recent Developments
Mar 30,2021: The United Laboratories International Holdings Announces 2020 Annual Results
Mar 05,2021: Construction impact of the expansion project of Zhuhai United Laboratories is announced before approval
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
The United Laboratories International Holdings Ltd (United Lab) is a pharmaceutical company that manufactures and sells pharmaceutical products. The company offers products through divisions such as preparation products, intermediate products, capsule products, raw material products, and health products. It also provides antibiotics, pharmaceutical raw materials and intermediates, material products and healthcare products. Its intermediates include amino-cephalosporanic acid, amino-penicillin acid, and octylammonium clavulanate. United Laboratories' drug products include amoxicillin capsules, ampicillin capsules, clavulana capsules, levofloxacin hydrochlorid, and cefuroxime axetil tablets, among others. It sells its products through a network of distributors in Europe, North America, East Africa and South East Asia. United Lab is headquartered in Hong Kong.
The United Laboratories International Holdings Ltd Key Recent Developments
Mar 30,2021: The United Laboratories International Holdings Announces 2020 Annual Results
Mar 05,2021: Construction impact of the expansion project of Zhuhai United Laboratories is announced before approval
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
The United Laboratories International Holdings Ltd - Key Facts
The United Laboratories International Holdings Ltd - Key Employees
The United Laboratories International Holdings Ltd - Key Employee Biographies
The United Laboratories International Holdings Ltd - Major Products and Services
The United Laboratories International Holdings Ltd - History
The United Laboratories International Holdings Ltd - Company Statement
The United Laboratories International Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
The United Laboratories International Holdings Ltd - Business Description
Product Category: 6-Aminopenicillin Acid (6-APA)
Performance
Product Category: Antibiotics Products
Performance
Product Category: Insulin Products
Performance
Product Category: Others
Performance
Product Category: Bulk Medicine
Overview
Performance
Product Category: Finished Products
Overview
Performance
Product Category: Intermediate products
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Middle East
Performance
Geographical Segment: Other Asian Regions
Performance
Geographical Segment: Other Regions
Performance
Geographical Segment: PRC, Including Hong Kong (Country of Domicile)
Performance
Geographical Segment: South America
Performance
R&D Overview
The United Laboratories International Holdings Ltd - Corporate Strategy
The United Laboratories International Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
The United Laboratories International Holdings Ltd - Strengths
The United Laboratories International Holdings Ltd - Weaknesses
The United Laboratories International Holdings Ltd - Opportunities
The United Laboratories International Holdings Ltd - Threats
The United Laboratories International Holdings Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 30, 2021: The United Laboratories International Holdings Announces 2020 Annual Results
Mar 05, 2021: Construction impact of the expansion project of Zhuhai United Laboratories is announced before approval
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
The United Laboratories International Holdings Ltd - Key Facts
The United Laboratories International Holdings Ltd - Key Employees
The United Laboratories International Holdings Ltd - Key Employee Biographies
The United Laboratories International Holdings Ltd - Major Products and Services
The United Laboratories International Holdings Ltd - History
The United Laboratories International Holdings Ltd - Company Statement
The United Laboratories International Holdings Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
The United Laboratories International Holdings Ltd - Business Description
Product Category: 6-Aminopenicillin Acid (6-APA)
Performance
Product Category: Antibiotics Products
Performance
Product Category: Insulin Products
Performance
Product Category: Others
Performance
Product Category: Bulk Medicine
Overview
Performance
Product Category: Finished Products
Overview
Performance
Product Category: Intermediate products
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: India
Performance
Geographical Segment: Middle East
Performance
Geographical Segment: Other Asian Regions
Performance
Geographical Segment: Other Regions
Performance
Geographical Segment: PRC, Including Hong Kong (Country of Domicile)
Performance
Geographical Segment: South America
Performance
R&D Overview
The United Laboratories International Holdings Ltd - Corporate Strategy
The United Laboratories International Holdings Ltd - SWOT Analysis
SWOT Analysis - Overview
The United Laboratories International Holdings Ltd - Strengths
The United Laboratories International Holdings Ltd - Weaknesses
The United Laboratories International Holdings Ltd - Opportunities
The United Laboratories International Holdings Ltd - Threats
The United Laboratories International Holdings Ltd - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Mar 30, 2021: The United Laboratories International Holdings Announces 2020 Annual Results
Mar 05, 2021: Construction impact of the expansion project of Zhuhai United Laboratories is announced before approval
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
The United Laboratories International Holdings Ltd, Key Facts
The United Laboratories International Holdings Ltd, Key Employees
The United Laboratories International Holdings Ltd, Key Employee Biographies
The United Laboratories International Holdings Ltd, Major Products and Services
The United Laboratories International Holdings Ltd, History
The United Laboratories International Holdings Ltd, Other Locations
The United Laboratories International Holdings Ltd, Subsidiaries
The United Laboratories International Holdings Ltd, Key Competitors
The United Laboratories International Holdings Ltd, Ratios based on current share price
The United Laboratories International Holdings Ltd, Annual Ratios
The United Laboratories International Holdings Ltd, Annual Ratios (Cont...1)
The United Laboratories International Holdings Ltd, Annual Ratios (Cont...2)
The United Laboratories International Holdings Ltd, Interim Ratios
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
The United Laboratories International Holdings Ltd, Key Facts
The United Laboratories International Holdings Ltd, Key Employees
The United Laboratories International Holdings Ltd, Key Employee Biographies
The United Laboratories International Holdings Ltd, Major Products and Services
The United Laboratories International Holdings Ltd, History
The United Laboratories International Holdings Ltd, Other Locations
The United Laboratories International Holdings Ltd, Subsidiaries
The United Laboratories International Holdings Ltd, Key Competitors
The United Laboratories International Holdings Ltd, Ratios based on current share price
The United Laboratories International Holdings Ltd, Annual Ratios
The United Laboratories International Holdings Ltd, Annual Ratios (Cont...1)
The United Laboratories International Holdings Ltd, Annual Ratios (Cont...2)
The United Laboratories International Holdings Ltd, Interim Ratios
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
The United Laboratories International Holdings Ltd, Performance Chart (2016 - 2020)
The United Laboratories International Holdings Ltd, Ratio Charts
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Performance Chart (2016 - 2020)
The United Laboratories International Holdings Ltd, Ratio Charts
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
The United Laboratories International Holdings Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021